Quanterix Stock (NASDAQ:QTRX)
Previous Close
$12.25
52W Range
$10.50 - $29.70
50D Avg
$13.40
200D Avg
$19.61
Market Cap
$460.16M
Avg Vol (3M)
$470.89K
Beta
1.36
Div Yield
-
QTRX Company Profile
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
QTRX Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
Product/Service | Dec 23 | Dec 22 | Dec 21 |
---|---|---|---|
Product revenue | $32.64M | $2.63M | $505.00K |
Service revenue. | $19.09M | - | - |
Undelivered licenses of intellectual property | - | $500.00K | $500.00K |
Service-type warranties and research services | - | $9.60M | $7.00M |
Service and other revenue | - | $11.00K | $114.00K |
Fiscal year ends in Dec 23 | Currency in USD
Peer Comparison
Ticker | Company |
---|---|
PRCT | PROCEPT BioRobotics Corporation |
TLIS | Talis Biomedical Corporation |
RPID | Rapid Micro Biosystems, Inc. |
CTKB | Cytek Biosciences, Inc. |
OFIX | Orthofix Medical Inc. |
SGHT | Sight Sciences, Inc. |
LUNG | Pulmonx Corporation |
TIVC | Tivic Health Systems, Inc. |
NPCE | NeuroPace, Inc. |
MXCT | MaxCyte, Inc. |
KIDS | OrthoPediatrics Corp. |
SIBN | SI-BONE, Inc. |
BBLG | Bone Biologics Corporation |
TCMD | Tactile Systems Technology, Inc. |
HSCS | Heart Test Laboratories, Inc. |
CVRX | CVRx, Inc. |
VVOS | Vivos Therapeutics, Inc. |